|
GW1929
- 品牌：MedKoo
- 產(chǎn)地：美國
- 貨號：526768
- cas：196808-24-9
- 發(fā)布日期： 2022-07-20
- 更新日期： 2024-08-12
產(chǎn)品詳請
| 產(chǎn)地 | 美國 |
| 品牌 | MedKoo |
| 貨號 | 526768 |
| 用途 | This product is for research use only, not for human or veterinary use. |
| 包裝規(guī)格 | 5.0mg; 10.0mg; 25.0mg; 50.0mg; 100.0mg; 200.0mg; 500.0mg; 1.0g; |
| CAS編號 | 196808-24-9 |
| 純度 | >98%% |
| 是否進(jìn)口 | 是 |
中文名稱:N-(2-苯甲酰基苯基)-O-[2-(甲基-2-吡啶基氨基)乙基]-L-酪氨酸
CAS No:196808-24-9
分子式:C30H29N3O4
沸點(diǎn):749.2°C at 760 mmHg
閃光點(diǎn):406.9°C
折射率:1.657
密度:1.264±0.06 g/cm3(Predicted)
用途:Highly selective orally active peroxisome proliferator-activated receptor (PPAR) γ agonist (pEC 50 values are 8.05, < 4 and < 4 for human PPAR γ , PPAR α and PPAR δ receptors respectively). Decreases glucose, fatty acid and triglyceride levels following oral administration in vivo .
CAS No:196808-24-9
分子式:C30H29N3O4
沸點(diǎn):749.2°C at 760 mmHg
閃光點(diǎn):406.9°C
折射率:1.657
密度:1.264±0.06 g/cm3(Predicted)
用途:Highly selective orally active peroxisome proliferator-activated receptor (PPAR) γ agonist (pEC 50 values are 8.05, < 4 and < 4 for human PPAR γ , PPAR α and PPAR δ receptors respectively). Decreases glucose, fatty acid and triglyceride levels following oral administration in vivo .
相關(guān)產(chǎn)品：
